Report Type: Therapy Reports
Report Category: Blood Diseases
Report Subcategory: Idiopathic Thrombocytopenic Purpura or Immune Thrombocytopenic Purpura
Price: 2999.00
Date: December 2021

Idiopathic Thrombocytopenic Purpura or Immune Thrombocytopenic Purpura : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Idiopathic Thrombocytopenic Purpura or Immune Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura also known to be Immune Thrombocytopenic Purpura, this type of diseased condition occurs when the immune system attacks platelets by mistake, thereby platelet count in blood gets decreased. 

Top 10 Companies:
F. Hoffmann-La Roche Ltd
Pfizer Inc
Bayer AG
Novartis AG
GlaxoSmithKline Plc
Sanofi
Takeda Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Amgen Inc
Eli Lilly and Co